1. Home
  2. OPTN vs LRFC Comparison

OPTN vs LRFC Comparison

Compare OPTN & LRFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPTN
  • LRFC
  • Stock Information
  • Founded
  • OPTN 2010
  • LRFC 2013
  • Country
  • OPTN United States
  • LRFC United States
  • Employees
  • OPTN N/A
  • LRFC N/A
  • Industry
  • OPTN Biotechnology: Pharmaceutical Preparations
  • LRFC Finance: Consumer Services
  • Sector
  • OPTN Health Care
  • LRFC Finance
  • Exchange
  • OPTN Nasdaq
  • LRFC Nasdaq
  • Market Cap
  • OPTN 78.4M
  • LRFC 68.2M
  • IPO Year
  • OPTN 2017
  • LRFC 2013
  • Fundamental
  • Price
  • OPTN $6.38
  • LRFC $23.92
  • Analyst Decision
  • OPTN Strong Buy
  • LRFC
  • Analyst Count
  • OPTN 3
  • LRFC 0
  • Target Price
  • OPTN $16.67
  • LRFC N/A
  • AVG Volume (30 Days)
  • OPTN 60.7K
  • LRFC 6.4K
  • Earning Date
  • OPTN 03-06-2025
  • LRFC 03-12-2025
  • Dividend Yield
  • OPTN N/A
  • LRFC 5.60%
  • EPS Growth
  • OPTN N/A
  • LRFC N/A
  • EPS
  • OPTN N/A
  • LRFC N/A
  • Revenue
  • OPTN $75,672,000.00
  • LRFC $19,936,000.00
  • Revenue This Year
  • OPTN $13.42
  • LRFC $3.63
  • Revenue Next Year
  • OPTN $38.54
  • LRFC N/A
  • P/E Ratio
  • OPTN N/A
  • LRFC N/A
  • Revenue Growth
  • OPTN 5.13
  • LRFC N/A
  • 52 Week Low
  • OPTN $4.82
  • LRFC $20.65
  • 52 Week High
  • OPTN $31.50
  • LRFC $26.00
  • Technical
  • Relative Strength Index (RSI)
  • OPTN 49.78
  • LRFC 38.64
  • Support Level
  • OPTN $5.16
  • LRFC $23.78
  • Resistance Level
  • OPTN $6.97
  • LRFC $24.80
  • Average True Range (ATR)
  • OPTN 0.66
  • LRFC 0.51
  • MACD
  • OPTN 0.10
  • LRFC -0.07
  • Stochastic Oscillator
  • OPTN 71.08
  • LRFC 20.59

About OPTN OptiNose Inc.

OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.

About LRFC Logan Ridge Finance Corporation

Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.

Share on Social Networks: